DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
19.97
-1.03 (-4.90%)
At close: Apr 21, 2026, 4:00 PM EDT
19.70
-0.27 (-1.35%)
After-hours: Apr 21, 2026, 5:20 PM EDT

DBV Technologies Revenue

In the year 2025, DBV Technologies had annual revenue of $5.64M with 35.77% growth. DBV Technologies had revenue of $645.00K in the quarter ending December 31, 2025, with 26.22% growth.

Revenue (ttm)
$5.64M
Revenue Growth
+35.80%
P/S Ratio
211.72
Revenue / Employee
$48,171
Employees
117
Market Cap
1.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.64M1.49M35.77%
Dec 31, 20244.15M-11.58M-73.61%
Dec 31, 202315.73M10.88M224.69%
Dec 31, 20224.84M-864.00K-15.14%
Dec 31, 20215.71M-5.57M-49.38%
Dec 31, 202011.28M-3.43M-23.33%
Dec 31, 201914.71M-2.00M-11.96%
Dec 31, 201816.71M2.42M16.90%
Dec 31, 201714.29M4.73M49.50%
Dec 31, 20169.56M2.86M42.76%
Dec 31, 20156.70M933.42K16.20%
Dec 31, 20145.76M498.99K9.48%
Dec 31, 20135.26M1.60M43.69%
Dec 31, 20123.66M1.24M51.01%
Dec 31, 20112.43M143.68K6.30%
Dec 31, 20102.28M734.19K47.44%
Dec 31, 20091.55M93.10K6.40%
Dec 31, 20081.45M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group376.13M
AbCellera Biologics75.13M
Septerna45.95M
EyePoint31.37M
Zenas BioPharma10.00M
Inhibrx Biosciences1.30M
Revenue Rankings